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INTRODUCTION
Skeletal muscle is an important tissue that supports body pos-
ture and internal organs. Most skeletal muscles are attached 
to their adjacent bones, and they interact with each other by 
releasing myokines and osteokines.1 This interaction has been 
described by many clinical studies, reporting that people with 
less muscle mass have lower bone mineral density (BMD) 
and face a higher risk of fracture.2 In addition, muscle is the 
primary site of glucose uptake after meal intake, and sarcope-
nia is highly associated with insulin resistance.3 According to 
one study, inflammatory responses from muscles may under-
lie the development of insulin resistance: when the inflamma-
tory response is inadequate as with aging muscle, acellular 
lipid droplets and adipocytes can accumulate.4 Accumulated 
adipocytes and lipid droplets, in turn, are presumed to affect 
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the development of insulin resistance, type 2 diabetes, and 
metabolic syndrome by secreting various adipokines, chemo-
kines, and cytokines. 
Although it has been speculated that muscle is closely relat-
ed to osteoporosis and metabolic abnormalities, there is lack 
of data on associations among muscle properties and bone 
mass or insulin resistance in the Asian population. Muscle 
mass and strength are widely used as indicators of muscle 
quantity and quality, respectively. Furthermore, it is a com-
mon belief that muscle mass and strength are correlated with 
each other.5 However, Hughes, et al.6 demonstrated that less 
than 5% of changes in muscle strength are attributable to 
changes in muscle size. Similarly, Barbat-Artigas, et al.7 report-
ed that women with sarcopenia who were 75 years of age and 
older showed better muscle quality than women without sar-
copenia, indicating a discordance between muscle quality 
and mass. Therefore, in addition to muscle quantity, muscle 
quality should be evaluated independently. Although muscle 
quality is usually measured by muscle strength, muscle com-
position (e.g., fiber type or lipid content) should also be taken 
into account, as different muscle compositions might explain 
why individuals with the same muscle mass do not necessari-
ly have the same muscle strength.7
In this study, we aimed to investigate which muscle proper-
ties, among muscle mass, muscle strength, physical perfor-
mance, or muscle composition, are associated with bone mass 
and insulin resistance in Korean postmenopausal women.
MATERIALS AND METHODS
Study subjects and anthropometry
A total of 192 postmenopausal women aged 60 years and old-
er were enrolled. The participants visited Severance Hospital 
in Seoul, Korea for a routine health check up from April 2016 
to September 2016. We excluded subjects who had been diag-
nosed with severe hepatic impairment [aspartate transami-
nase (AST) or alanine transaminase (ALT) levels higher than 
three times the upper limit of the normal range within the last 
3 months] or malignancy and those who had been treated 
with a glucocorticoid or levothyroxine. Subjects who were 
treated with menopausal hormone therapy within 3 years 
were also excluded. Subjects whose glycosylated hemoglobin 
was ≥6.5% at baseline screening and who had been treated 
with oral hypoglycemic agents or insulin were defined to have 
diabetes mellitus. Medication history, including use of 
bisphosphonates, selective estrogen receptor modulators 
(SERM), oral hypoglycemic agents, and insulin, was collected 
from the electronic medical records system of Severance Hos-
pital. The subjects completed a simple questionnaire con-
cerning their age at menopause, osteoporotic fracture history, 
smoking history, and times of regular exercise per week. 
Height and body weight were measured using a calibrated 
digital scale after all outer clothing and shoes were removed, 
and body mass index (BMI) was calculated as weight in kilo-
grams divided by height in meters squared (kg/m2). Moreover, 
waist circumference was measured as the minimum circum-
ference between the inferior border of the rib cage and the su-
perior aspect of the iliac crest using an inelastic measuring 
tape. Hip circumference was measured as the maximum cir-
cumference at the level of the buttocks. All anthropometric 
measurements were performed by the same evaluator. Using 
quantitative computed tomography (QCT), osteoporosis was 
defined as an L1–L4 average spine BMD value of <80 mg/cm3 
or a T-score at the hip of <-2.5, based on the American College 
of Radiology guidelines.8 The Severance Hospital Institutional 
Review Board approved the study protocol (IRB No. 4-2016-
0126), and informed consent was obtained from all subjects. 
In addition, all investigations were performed in accordance 
with the principles of the Declaration of Helsinki. 
Biochemical measurements
Serum fasting glucose, fasting insulin, blood urea nitrogen, se-
rum creatinine, AST, ALT, total cholesterol, and 25-hydroxyvita-
min D were measured. Serum 25-hydroxyvitamin D levels 
were measured using a radioimmunoassay [RIA: INCSTAR 
Corp., Stillwater, MN, USA; intraassay coefficient of variation 
(CV) <4.1% and interassay CV <7.0%]. Homeostatic model as-
sessment-insulin resistance (HOMA-IR), which is an index of 
insulin resistance, was calculated using the following equa-
tion, as described by Matthews, et al.9:
HOMA-IR=[glucose (mg/dL)×insulin (µU/mL)]/405.
QCT scanning
The subjects were scanned on a multidetector CT scanner 
(Light Speed QX-I scanner, GE Medical Systems, Waukesha, 
WI, USA) at 120 kVp and 120 mAs, with a 2.5-mm slice thick-
ness, as previously described.10-12 Volumetric BMD in mg/cm3 
was calculated at the spine and hip, and all scanned data were 
analyzed using QCT PRO software (Mindways Software, Aus-
tin, TX, USA). 
Measurement of muscle mass and composition
The cross-sectional area (CSA) of the gluteus maximus and 
quadriceps muscles was used as an index of muscle mass.13,14 
Axial images were obtained using QCT, and CSA was mea-
sured using freehand-drawn regions of interest (ROIs) (Sup-
plementary Fig. 1, only online). Gluteus maximus and quadri-
ceps muscle area was measured at the level of the symphysis 
pubis and at the level 7 cm from the lesser trochanter, respec-
tively. At each level, the mean value of right and left area was 
calculated and used for analysis. As an index of muscle com-
position, we used the mean attenuation of coefficient, mea-
sured in Hounsfield units (HU).15 The mean HU was mea-
sured at the same ROIs where muscle CSA was measured. All 
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images were analyzed by a single investigator.
Measurement of muscle strength and physical 
performance
To estimate muscle strength and physical performance, the 
hand grip test (HGT) and Short Physical Performance Battery 
(SPPB) were performed. Hand grip strength was evaluated 
using a digital dynamometer (Grip Strength Dynamometer 
T.K.K.5401; Takei Co., Tokyo, Japan). The subjects were asked 
to stand straight with their arms resting in a neutral position, 
and grip strength was measured three times with each hand.16 
The maximum score was recorded and used for analysis. The 
SPPB score was based on three tests, as follows: balance test, 
gait speed test, and chair stand test. For the balance test, the 
subjects were asked to hold challenging standing positions for 
10 s each: 1) side-by-side position, feet together side-by-side; 
2) semi-tandem position, heel of one foot against the side of 
the big toe of the other foot; and 3) tandem position, feet 
aligned heel to toe. Moreover, the time to walk 4 m at the sub-
ject’s usual pace was measured to evaluate gait speed. For the 
chair stand test, the subjects were asked to sit down and stand 
up from a chair five times without using their arms, and the 
total time was measured. Each test was scored between 0 and 
4; a total score of 12 was the maximum score.17 These tests were 
conducted only for subjects who agreed to perform them. 
Among the 192 enrolled subjects, 173 completed HGT and 83 
performed the SPPB test. Seventy-two subjects completed 
both tests.
Statistical analysis
Descriptive statistics were performed for the analysis of base-
line characteristics. To evaluate the relationship between mus-
cle properties and BMD or HOMA-IR, Pearson correlation 
analysis and linear regression test were performed. Analysis of 
covariance was used to evaluate significant differences in 
muscle properties between osteoporotic and non-osteoporot-
ic groups or between diabetic and non-diabetic groups. Val-
ues are expressed as means±standard deviations. p-values 
<0.05 were considered statistically significant. All statistical 
analyses were performed with the Statistical Package for So-
cial Sciences for Windows, version 23.0 (IBM Corp., Armonk, 
NY, USA) and GraphPad Prism 5 (GraphPad Software Inc., 
San Diego, CA, USA). 
RESULTS
The baseline characteristics are shown in Table 1. The mean 
age of the subjects was 72.39±6.07 years, and their mean BMI 
was 23.6±3.43 kg/m2. According to the World Health Organi-
zation criteria,18,19 57 subjects (29.7%) were obese (BMI >25 
kg/m2) and 89 (46.4%) had abdominal obesity (waist-hip ratio 
>0.85). One hundred and nine subjects (56.8%) had osteopo-
Table 1. Baseline Characteristics of the Subjects
Variable Value
Age (yr) 72.39±6.07
Height (cm) 154.67±4.78
Weight (kg) 56.43±8.34
BMI (kg/m2) 23.60±3.43
Waist circumference (cm) 80.36±9.23
Hip circumference (cm) 93.91±6.98
Waist/hip ratio 0.86±0.72
Age at menopause (yr) 49.52±6.23
Times of exercise/week, n (%)
None 23 (12.0)
1–2 48 (25.0)
3–5 86 (44.8)
6–7 35 (18.2)
History of spine or femur fracture, n (%) 14 (7.3)
Smoking history (n)
Never smoker 188
Ex-smoker or current smoker 4
Subjects with osteoporosis, n (%) 109 (56.8)
Subjects with diabetes mellitus, n (%) 55 (28.6)
Medication history (n)
Bisphosphonates 73
SERM 21
Oral hypoglycemic agent 51
Metformin 48
Thiazolidinediones 5
Insulin 3
Glucose (mg/dL) 107.02±18.39
Glycosylated hemoglobin 6.32±0.72
Fasting insulin (µU/mL) 8.54±6.45
BUN (mg/dL) 16.46±5.06
Serum Cr (mg/dL) 0.70±0.17
AST (IU/L) 23.34±10.00
ALT (IU/L) 19.94±11.72
Total cholesterol (mg/dL) 179.60±32.12
25-hydroxyvitamin D (ng/mL) 34.09±11.24
HOMA-IR 2.24±1.91
Spine BMD (mg/cm3) 73.03±23.71
Hip BMD (mg/cm3) 241.487±36.72
CSA of gluteus maximus muscle (mm2) 3228.50±625.23 
CSA of quadriceps muscle (mm2) 3385.60±547.74 
Gluteus maximus muscle attenuation (HU) 23.74±12.32
Quadriceps muscle attenuation (HU) 47.98±7.31
Hand grip strength (kg) 19.33±4.21
SPPB score 9.93±2.23
BMI, body mass index; SERM, selective estrogen receptor modulators; BUN, 
blood urea nitrogen; Cr, creatinine; AST, aspartate transaminase; ALT, alanine 
transaminase; HOMA-IR, homeostatic model assessment-insulin resistance; 
BMD, bone mineral density; CSA, cross-sectional area; SPPB, Short Physical 
Performance Battery.
Values are expressed as means±standard deviations unless otherwise no-
ticed.
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Fig. 1. Scatterplot analysis of BMD with muscle CSA (A and B), hand grip strength (C), SPPB score (D), and muscle attenuation (E and F). Spine BMD and 
hip BMD according to SPPB score (G and H). BMD, bone mineral density; CSA, cross-sectional area; SPPB, Short Physical Performance Battery.
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rosis, among whom 94 had been treated with bisphospho-
nates (n=73) or SERM (n=21). Fifty-five subjects (28.6%) were 
diagnosed with diabetes mellitus, and 51 subjects (26.6%) had 
been taking oral hypoglycemic agents and/or receiving insu-
lin treatment. The numbers of subjects who were treated with 
metformin or thiazolidinediones, which can affect lipid accu-
mulation in muscle or bone loss, were 48 and 5, respectively. 
There were no significant differences in clinical parameters, 
including age, BMI, glycosylated hemoglobin, BMD, CSA of 
muscle, and muscle HU value, between the subjects who opt-
ed to participate in performance tests (e.g., HGT, SPPB, or 
both) and those who opted not to participate.
Muscle measurements and their association with BMI
The mean CSA values of the gluteus maximus and quadriceps 
muscles were 3228.50±625.23 mm2 and 3385.60±547.74 mm2, 
respectively. The muscle attenuation (HU) of the gluteus 
maximus and quadriceps was 23.74±12.32 HU and 47.98±7.31 
HU, respectively. The muscle area of the gluteus maximus and 
quadriceps was positively correlated with BMI (r=0.376, 
p<0.001 and r=0.214, p=0.009, respectively), whereas muscle 
attenuation (HU) of the gluteus maximus and quadriceps was 
inversely correlated with BMI (r=-0.440, p<0.001 and r=-0.347, 
p<0.001, respectively).
Association between muscle properties and BMD
As shown in Fig. 1A and B, the CSA of the gluteus maximus 
muscle was positively correlated with spine and hip BMD (r= 
0.218, p=0.006 and r=0.275, p<0.001, respectively). Moreover, 
the CSA of the quadriceps also showed a positive correlation 
with the spine and hip BMDs (r=0.259, p=0.001 and r=0.273, 
p=0.001, respectively). These associations remained signifi-
cant after adjusting for covariates (Table 2). Furthermore, 
muscle strength and physical performance, as well as muscle 
CSA, had a positive correlation with BMD. Both hand grip 
strength and SPPB score were positively correlated with BMD 
(Fig. 1C and D). Although the association between SPPB score 
and BMD was not significant after adjusting for covariates, the 
association between hand grip strength and BMD remained 
significant after adjusting for multiple confounding factors 
(Table 2). However, the HU value of the gluteus maximus or 
quadriceps muscles was not related to BMD (Fig. 1E and F), 
suggesting that muscle composition was not associated with 
BMD, unlike muscle area, strength, and physical perfor-
mance. As SPPB score did not have Gaussian distribution, we 
performed further analysis for classes according to SPPB score 
(Fig. 1G and H). Subjects whose SPPB score was 10 or more 
showed statistically significant higher spine BMD and hip 
BMD, compared to those with a SPPB score of less than 10.
Association between muscle properties and insulin 
resistance
As shown in Fig. 2A-D, muscle CSA, strength, and physical 
performance were not correlated with insulin resistance, 
whereas muscle attenuation (HU) of the gluteus maximus 
and quadriceps was inversely related to HOMA-IR, as shown 
in Fig. 2E and F (r=-0.194, p=0.018 and r=-0.292, p<0.001, re-
spectively). This association remained significant after adjust-
ing for confounding factors (Table 3).
Table 2. Correlation between BMD and Muscle Parameters
Spine BMD Hip BMD
β (SE) p value β (SE) p value
Gluteus maximus muscle area 0.218 (0.003) 0.006 0.275 (0.004) <0.001
Model 1 0.203 (0.003) 0.015 0.207 (0.005) 0.014
Model 2 0.192 (0.003) 0.026 0.208 (0.005) 0.016
Model 3 0.224 (0.003) 0.012 0.228 (0.005) 0.011
Quadriceps muscle area 0.259 (0.003) 0.001 0.273 (0.005) 0.001
Model 1 0.172 (0.003) 0.038 0.189 (0.005) 0.024
Model 2 0.220 (0.004) 0.011 0.202 (0.006) 0.021
Model 3 0.196 (0.004) 0.026 0.184 (0.006) 0.041
Hand grip strength 0.263 (0.431) 0.001 0.268 (0.678) 0.001
Model 1 0.169 (0.463) 0.041 0.191 (0.726) 0.022
Model 2 0.191 (0.491) 0.031 0.196 (0.781) 0.027
Model 3 0.201 (0.506) 0.027 0.177 (0.802) 0.050
SPPB score 0.415 (1.168) <0.001 0.332 (1.880) 0.004
Model 1 0.224 (1.265) 0.054 0.184 (2.046) 0.129
Model 2 0.174 (1.379) 0.160 0.200 (2.545) 0.153
Model 3 0.205 (1.409) 0.107 0.215 (2.691) 0.146
BMD, bone mineral density; SPPB, Short Physical Performance Battery; BMI, body mass index; eGFR, estimated glomerular filtration rate; SERM, selective estro-
gen receptor modulators; AST, aspartate transaminase; ALT, alanine transaminase; HOMA-IR, homeostatic model assessment-insulin resistance.
Model 1 adjusted for age and BMI; model 2 adjusted for model 1 parameters+eGFR, HOMA-IR, AST, ALT, total cholesterol and 25-hydroxyvitamin D; model 3 ad-
justed for model 2 parameters+physical activity (exercise/week), medication history (SERM, metformin or thiazolidinediones) and smoking history.
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Muscle properties according to the presence of 
osteoporosis or diabetes mellitus
We further analyzed muscle properties depending on the 
presence of osteoporosis (Fig. 3A, B, and C). We investigated 
statistical differences between the two groups after adjusting 
for age. As shown in Fig. 3A, subjects with osteoporosis showed 
significantly smaller gluteus maximus and quadriceps muscle 
area than the control group. However, muscle strength, physi-
cal performance, and muscle attenuation measured as HU 
were not different between the two groups (Fig. 3B and C). In 
addition, muscle properties according to the presence of dia-
betes were also analyzed after adjusting for age. Subjects with 
diabetes had significantly higher gluteus maximus muscle 
area; however, there were no differences in quadriceps area, 
muscle strength, and physical performance (Fig. 3D and E). 
Moreover, the muscle attenuation (HU) of subjects with dia-
betes was significantly lower than that of subjects without dia-
betes (Fig. 3F). 
DISCUSSION
In this study, associations between muscle properties and 
BMD or insulin resistance were assessed by measuring mus-
cle parameters, including CSA, strength, attenuation (HU) of 
lean tissue, and physical performance in Korean postmeno-
pausal women. Here, we provide clinical evidence that mus-
cle mass, strength, and physical performance are associated 
primarily with low bone mass. Furthermore, we also recon-
firmed that persistently damaged muscles, represented by ac-
Fig. 2. Scatterplot analysis of HOMA-IR with muscle CSA (A and B), hand grip strength (C), SPPB score (D), and muscle attenuation (E and F). HOMA-IR, 
homeostatic model assessment-insulin resistance; CSA, cross-sectional area; SPPB, Short Physical Performance Battery.
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cumulated adipocytes and lipid droplets, not simply low mus-
cle mass or strength, are closely related to insulin resistance.
In our study, QCT was used to measure muscle CSA and 
composition. Compared to dual-energy X-ray absorptiome-
try, QCT can evaluate muscle composition and is less affected 
by degenerative bone changes and vascular calcifications. 
Muscle area and strength showed significant positive correla-
tions with BMD after adjusting for confounding factors, such 
as age and body weight, which is consistent with the results of 
previous studies.20-22 However, SPPB score, which was used to 
measure physical performance, was not significant after ad-
justing for confounding factors. Furthermore, when the sub-
jects were divided into two groups according to the presence 
of osteoporosis, hand grip strength and SPPB score were not 
significantly different between the two groups. Previous stud-
ies reported that quadriceps strength and physical perfor-
mance measurements, such as gait speed and brisk step 
length, are associated with BMD.23,24 There is a possibility that 
hand grip strength in our study could not reflect thigh muscle 
strength well enough, as it simply assesses the strength of the 
forearm muscles. In addition, the number of subjects who 
completed SPPB was relatively small. This may also contrib-
ute to the insignificant relationship between SPPB score and 
BMD after adjusting for confounding factors.
Lang, et al.25 previously reported that only muscle HU value 
had a significant association with increased risk of hip fracture 
after adjusting for covariates, such as age, race, sex, and BMI. 
However, we could not find any association between muscle 
HU values and BMD. These somewhat discordant findings 
might be due to the different baseline characteristics of the 
study population. The subjects enrolled in the study of Lang, et 
al.25 had higher BMI (26.0–29.5 kg/m2 depending on ethnicity 
and sex) and lower thigh muscle HU value (32.6–37.5 HU de-
pending on ethnicity and sex) compared with the subjects in 
our study (BMI of 23.60 kg/m2 and quadriceps HU of 47.98). 
Therefore, it can be speculated that large accumulation of 
muscle fat accompanied by aggravated myositis could de-
crease muscle HU value and further lead to osteoporosis, fol-
lowed by an increased risk of fracture.
Sarcopenia is known to be significantly associated with in-
sulin resistance and diabetes.26,27 In previous studies, sarcope-
nia was defined using a lean mass index (appendicular lean 
Table 3. Correlation between HOMA-IR and Muscle Attenuation
HOMA-IR
β (SE) p value
Gluteus maximus muscle attenuation -0.194 (0.013) 0.018
Model 1 -0.204 (0.013) 0.016
Model 2 -0.212 (0.012) 0.008
Model 3 -0.199 (0.013) 0.013
Quadriceps muscle attenuation -0.292 (0.021) <0.001
Model 1 -0.295 (0.021) <0.001
Model 2 -0.278 (0.020) <0.001
Model 3 -0.230 (0.021) 0.004
HOMA-IR, homeostatic model assessment-insulin resistance; BMI, body 
mass index; eGFR, estimated glomerular filtration rate; SERM, selective es-
trogen receptor modulators; AST, aspartate transaminase; ALT, alanine trans-
aminase; BMD, bone mineral density.
Model 1 adjusted for age and BMI; model 2 adjusted for model 1 
parameters+eGFR, AST, ALT and total cholesterol; model 3 adjusted for mod-
el 2 parameters+hip BMD, physical activity (exercise/week), medication his-
tory (SERM, metformin or thiazolidinediones), smoking history and fracture 
history.
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Fig. 3. Muscle parameters in subjects with osteoporosis (A, B, and C) and diabetes (E, E, and F). Muscle CSA is shown in (A) and (D), physical perfor-
mance in (B) and (E), and muscle composition in (C) and (F). *p≤0.05 versus non-osteoporotic (A, B, and C) or non-diabetic group (D, E, and F). CSA, cross-
sectional area; HGT, hand grip test; SPPB, Short Physical Performance Battery. 
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mass in kg/height in meter squared).28 However, this approach 
is limited in that it cannot evaluate the association of each 
muscle property with diabetes or osteoporosis. In the present 
study, we used QCT and performance tests to analyze not 
only muscle CSA but also muscle composition and perfor-
mance, which are closely related to functional impairment and 
disability. According to our study, muscle CSA, strength, and 
physical performance were not associated with insulin resis-
tance, whereas muscle HU value was significantly associated 
with insulin resistance: subjects with lower HU value in mus-
cle, which means more fat infiltration, showed higher insulin 
resistance. Therefore, our present findings implicate persis-
tently damaged muscles accompanied by fatty infiltration in 
the development of insulin resistance. Several studies have 
explored the association of sarcopenia with muscle adiposity 
and insulin resistance.29-31 Cell death processes occur in re-
sponse to muscle disuse or age-associated sarcopenia.29 
When apoptotic cells accumulate and their clearance is im-
paired, maladaptive muscle remodeling occurs with fatty infil-
tration within the muscle.4 Meanwhile, inflammatory cyto-
kines and adipokines are released, which might lead to the 
development of insulin resistance. Therefore, this gave rise to 
the idea that the presence of local inflammation in muscle, 
followed by fat accumulation and secretion of dysregulated 
adipokines and cytokines, rather than decreased muscle mass 
or strength alone, may play a more important role in insulin 
resistance development. In this regard, our results can provide 
clinical evidence that supports the results of other studies.32-34
Racial differences in bone mass, body composition, and in-
sulin resistance have been reported in previous studies.35-37 
However, most studies regarding the relationships between 
muscle, bone, and fat have only included non-Hispanic white, 
black, and Hispanic subjects. In this study, we focused on the 
Korean population. The prevalence of obesity in Korean adults 
(31%) is reported to be lower than in the general population of 
the United States (35%).38,39 In this study, the percentage of sub-
jects with obesity was 29.7%, which was even lower than that 
of the general Korean population. Although fatty infiltration 
within the muscle in our subjects was not severe, we found a 
clear negative association between muscle HU value and in-
sulin resistance. Therefore, it could be speculated that fat de-
position indeed has a close positive relationship with insulin 
resistance. In contrast, there was no association between 
muscle HU value and BMD.
To the best of our knowledge, this is the first study to focus 
on individual muscle properties and their associations with 
BMD and insulin resistance in Korean postmenopausal wom-
en. However, this study has several limitations. First, as the 
current study only included postmenopausal women who 
were ≥60 years old, the results cannot be applied to men and 
premenopausal women who may have different body com-
position and metabolic conditions than postmenopausal 
women. Second, we did not perform muscle biopsy, which can 
directly evaluate muscle composition, and muscle attenua-
tion values were used as an alternative method. However, a 
previous study showed that muscle attenuation can actually 
reflect skeletal muscle lipid content.40 Therefore, we believe 
that muscle attenuation could be used as a non-invasive and 
reliable method to evaluate muscle composition, although it 
is not as accurate as muscle biopsy. Third, since this was a 
cross-sectional study, we could not investigate the causative 
effect or influence of muscle properties on BMD and insulin 
resistance. Lastly, calcium and vitamin D intake from diet and 
supplements was not assessed, and although the use of medi-
cations, such as bisphosphonates, SERM, metformin, and thi-
azolidinediones, was adjusted for, we cannot exclude the pos-
sibility that the use of these medications influenced the results. 
In conclusion, we found that each muscle property plays a 
different role in balancing bone metabolism and insulin sen-
sitivity in Korean postmenopausal women. That is, the prop-
erties associated with osteoporosis are muscle area, strength, 
and physical performance, whereas the muscle feature related 
to insulin resistance is muscle composition, including fat ac-
cumulation. Further studies are needed to investigate how dif-
ferent muscle features are distinctively associated with bone 
mass and insulin resistance.
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